Ligand profile
6NF
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0681 — alpha/beta hydrolase fold family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
6NF- PDB
5aki- UniProt (similar protein)
P34913- Target protein
- VK055_0681
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 53.6
- −1 ≤ LogP ≤ 5 3.46
- MW ≤ 500 Da 256.4
- LogP ≤ 5 3.46
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 53.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cnccc1c2cc(n[nH]2)NCC3CCCCC3c1cnccc1c2cc(n[nH]2)NCC3CCCCC3
InChI=1S/C15H20N4/c1-2-4-12(5-3-1)11-17-15-10-14(18-19-15)13-6-8-16-9-7-13/h6-10,12H,1-5,11H2,(H2,17,18,19)InChI=1S/C15H20N4/c1-2-4-12(5-3-1)11-17-15-10-14(18-19-15)13-6-8-16-9-7-13/h6-10,12H,1-5,11H2,(H2,17,18,19)
PAVOZTULRSGNJC-UHFFFAOYSA-NPAVOZTULRSGNJC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 6NF →
- PDB RCSB structure 5aki →
- UniProt UniProt P34913 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “6NF”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0681.
PDB 98
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).